The use of folic acid in dengue: has it any value?

Ahsan Ali Syed; Saad Bin Zafar; Asif Ali Shah; Safia Awan

doi:10.1177/0049475519827110

The use of folic acid in dengue: has it any value?

Ahsan Ali Syed, Saad Bin Zafar, Asif Ali Shah, Safia Awan

Department of Medicine, Medical College, Pakistan

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Folic acid is used in dengue patients. Our study aims to compare the duration of recovery of thrombocytopenia in patients with dengue infection who received folic acid and those who did not. We retrospectively reviewed the medical records of adult patients admitted over six years with a diagnosis of dengue. Of 2216 patients, 1464 fulfilled the inclusion criteria. Group A were those patients who received folic acid and group B were those who did not. A total of 1322 (90.3%) patients received folic acid. The mean time period required for platelets to double the nadir was 1.7 (±2.2) days in both groups A and B (P = 0.89). In conclusion, there is no significant difference in the recovery of thrombocytopenia in patients with dengue fever who received folic and those who did not receive folic acid.

Original language	English
Pages (from-to)	85-87
Number of pages	3
Journal	Tropical Doctor
Volume	49
Issue number	2
DOIs	https://doi.org/10.1177/0049475519827110
Publication status	Published - 1 Apr 2019

Keywords

Dengue
folic acid
thrombocytopenia

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1177/0049475519827110

Cite this

@article{a749cbc12c084a52be2a896979b2d760,

title = "The use of folic acid in dengue: has it any value?",

abstract = "Folic acid is used in dengue patients. Our study aims to compare the duration of recovery of thrombocytopenia in patients with dengue infection who received folic acid and those who did not. We retrospectively reviewed the medical records of adult patients admitted over six years with a diagnosis of dengue. Of 2216 patients, 1464 fulfilled the inclusion criteria. Group A were those patients who received folic acid and group B were those who did not. A total of 1322 (90.3%) patients received folic acid. The mean time period required for platelets to double the nadir was 1.7 (±2.2) days in both groups A and B (P = 0.89). In conclusion, there is no significant difference in the recovery of thrombocytopenia in patients with dengue fever who received folic and those who did not receive folic acid.",

keywords = "Dengue, folic acid, thrombocytopenia",

author = "{Ali Syed}, Ahsan and {Bin Zafar}, Saad and {Ali Shah}, Asif and Safia Awan",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2019.",

year = "2019",

month = apr,

day = "1",

doi = "10.1177/0049475519827110",

language = "English",

volume = "49",

pages = "85--87",

journal = "Tropical Doctor",

issn = "0049-4755",

publisher = "SAGE Publications Ltd",

number = "2",

}

TY - JOUR

T1 - The use of folic acid in dengue

T2 - has it any value?

AU - Ali Syed, Ahsan

AU - Bin Zafar, Saad

AU - Ali Shah, Asif

AU - Awan, Safia

N1 - Publisher Copyright: © The Author(s) 2019.

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Folic acid is used in dengue patients. Our study aims to compare the duration of recovery of thrombocytopenia in patients with dengue infection who received folic acid and those who did not. We retrospectively reviewed the medical records of adult patients admitted over six years with a diagnosis of dengue. Of 2216 patients, 1464 fulfilled the inclusion criteria. Group A were those patients who received folic acid and group B were those who did not. A total of 1322 (90.3%) patients received folic acid. The mean time period required for platelets to double the nadir was 1.7 (±2.2) days in both groups A and B (P = 0.89). In conclusion, there is no significant difference in the recovery of thrombocytopenia in patients with dengue fever who received folic and those who did not receive folic acid.

AB - Folic acid is used in dengue patients. Our study aims to compare the duration of recovery of thrombocytopenia in patients with dengue infection who received folic acid and those who did not. We retrospectively reviewed the medical records of adult patients admitted over six years with a diagnosis of dengue. Of 2216 patients, 1464 fulfilled the inclusion criteria. Group A were those patients who received folic acid and group B were those who did not. A total of 1322 (90.3%) patients received folic acid. The mean time period required for platelets to double the nadir was 1.7 (±2.2) days in both groups A and B (P = 0.89). In conclusion, there is no significant difference in the recovery of thrombocytopenia in patients with dengue fever who received folic and those who did not receive folic acid.

KW - Dengue

KW - folic acid

KW - thrombocytopenia

UR - http://www.scopus.com/inward/record.url?scp=85061570326&partnerID=8YFLogxK

U2 - 10.1177/0049475519827110

DO - 10.1177/0049475519827110

M3 - Article

C2 - 30755107

AN - SCOPUS:85061570326

SN - 0049-4755

VL - 49

SP - 85

EP - 87

JO - Tropical Doctor

JF - Tropical Doctor

IS - 2

ER -

The use of folic acid in dengue: has it any value?

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this